Tvardi Therapeutics, Inc. (TVRD) › Net IncomeTvardi Therapeutics, Inc. (TVRD) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: -$6.27M2013: -$3.96M2014: -$17.75M2015: -$24.69M2016: -$57.28M2017: -$58.12M2018: -$74.01M2019: -$106.37M2020: $8.41M2021: -$88.44M2022: -$85.47M2023: -$118.51M2024: -$29.40M2025: -$18.21M-$18.21M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$18.21M+38.0%2024-$29.40M+75.2%2023-$118.51M-38.7%2022-$85.47M+3.4%2021-$88.44M-1151.6%2020$8.41M+107.9%2019-$106.37M-43.7%2018-$74.01M-27.3%2017-$58.12M-1.5%2016-$57.28M-132.0%2015-$24.69M-39.1%2014-$17.75M-347.8%2013-$3.96M+36.8%2012-$6.27M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share